AKT1 and colitis: We have identified a novel mechanism by which FMT with Akkermansia as the core flora inhibits the PI3K-Akt signaling pathway and MAPK signaling pathway via the bacterial metabolites butyric acid and deoxycholic acid to treat C. jejuni infection in the host organism and alleviate colitis.